Cardiopulmonary involvement in Fabry's disease

被引:9
|
作者
Koskenvuo, Juha W. [1 ,2 ]
Kantola, Ilkka M. [3 ]
Nuutila, Pirjo [2 ,3 ]
Knuuti, Juhani [2 ]
Parkkola, Riitta [4 ]
Mononen, Ilkka [5 ]
Hurme, Saija [6 ]
Kalliokoski, Riikka [2 ]
Viikari, Jorma S. [3 ]
Wendelin-Saarenhovi, Maria [1 ,2 ]
Kiviniemi, Tuomas O. [1 ]
Hartiala, Jaakko J. [1 ,2 ]
机构
[1] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland
[2] Univ Turku, Turku PET Ctr, Turku, Finland
[3] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland
[4] Turku Univ Hosp, Dept Radiol, FIN-20520 Turku, Finland
[5] Turku Univ Hosp, Dept Clin Chem, FIN-20520 Turku, Finland
[6] Univ Turku, Dept Biostat, Turku, Finland
关键词
Fabry's disease; cardiopulmonary involvement; MRI; HRCT; spirometry; diffusing capacity; symptoms; BLOOD-PRESSURE; CLINICAL-MANIFESTATIONS; PULMONARY INVOLVEMENT; REPLACEMENT THERAPY; NATURAL-HISTORY; EXERCISE; PREVALENCE; CARDIOMYOPATHY; HYPERTROPHY; PARAMETERS;
D O I
10.2143/AC.65.2.2047052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Fabry's disease is an X-linked lysosomal storage disease caused by deficiency of alpha-galactosidase A enzyme activity. Decreased enzyme activity leads to accumulation of glycosphingolipid in different tissues, including endothelial and smooth-muscle cells and cardiomyocytes. Objectives - There is controversial data on cardiopulmonary involvement in Fabry's disease, because many reports are based on small and selected populations with Fabry's disease. Furthermore, the aetiology of cardiopulmonary symptoms in Fabry's disease is poorly understood. Methods - We studied cardiopulmonary involvement in seventeen patients with Fabry's disease (20-65 years, 6 men) using ECG, bicycle stress, cardiac magnetic resonance imaging, spirometry, diffusing capacity and pulmonary high-resolution computed tomography (HRCT) tests. Cardiopulmonary symptoms were compared to observed parameters in cardiopulmonary tests. Results - Left ventricular hypertrophy (LVH) and reduced exercise capacity are the most apparent cardiac changes in both genders with Fabry's disease. ECG parameters were normal when excluding changes related to LVH. Spirometry showed mild reduction in vital capacity and forced expiratory volume in one second (FEVI), and mean values in diffusing capacity tests were within normal limits. Generally, only slight morphological pulmonary changes were detected using pulmonary HRCT, and they were not associated with changes in pulmonary function. The self-reported amount of pulmonary symptoms associated only with lower ejection fraction (P < 0.001) and longer QRS-duration (P = 0.04) of all measured cardiopulmonary parameters, whereas cardiac symptoms have no statistically significant association with any of these parameters. Conclusion - LVH and reduced exercise capacity are the most apparent cardiopulmonary changes in Fabry's disease but they have only a minor association to cardiopulmonary symptoms. Therefore, routine cardiopulmonary evaluation in Fabry's disease using echocardiography is maybe enough when integrated to counselling for aerobic exercise training.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 50 条
  • [1] Cardiac involvement in Fabry's disease
    Weidemann, Frank
    Breunig, Frank
    MEDIZINISCHE KLINIK, 2008, 103 (03) : 161 - 165
  • [2] Renal involvement in Fabry's disease
    Okuda, S
    INTERNAL MEDICINE, 2000, 39 (08) : 601 - 602
  • [3] Cardiopulmonary exercise testing in Fabry's disease.
    Bierer, G
    Kamangar, N
    Balfe, D
    Wilcox, W
    Mohsenifar, Z
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S168 - S168
  • [4] Lymph node involvement in Fabry's disease
    Mellen, PF
    Ownbey, JL
    Seikan, G
    Moore, J
    Swanson, SJ
    Shaver, TR
    JOURNAL OF NEUROLOGICAL AND ORTHOPAEDIC MEDICINE AND SURGERY, 1996, 17 (01): : 1 - 3
  • [5] Echocardiographic features of cardiac involvement in Fabry's disease
    Nakayama, Y
    Tsumura, K
    Yoshimaru, K
    HEART, 2000, 83 (06) : 695 - 695
  • [6] Cardiopulmonary exercise testing in Fabry disease
    Bierer, G
    Kamangar, N
    Balfe, D
    Wilcox, WR
    Mosenifar, Z
    RESPIRATION, 2005, 72 (05) : 504 - 511
  • [7] CARDIAC INVOLVEMENT IN FABRY DISEASE
    Caballero, L.
    Climent, V.
    Quintanilla, M. A.
    Marin, F.
    Garcia Honrubia, A.
    Perez Berbel, P.
    Sanchez Quinones, J.
    Sogorb, F.
    CLINICAL THERAPEUTICS, 2010, 32 : S107 - S108
  • [8] Colonic Involvement in Fabry Disease
    Deniz, Kemal
    Yurci, Alper
    Yagbasan, Ahmet
    Tekelioglu, Fatos
    Gursoy, Sebnem
    Guven, Kadri
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2011, 19 (06) : 777 - 778
  • [9] Fabry Disease and Cardiovascular Involvement
    Anastasakis, Aris
    Papatheodorou, Efstathios
    Steriotis, Alexandros Klavdios
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 5997 - 6008
  • [10] Cardiac involvement in Fabry disease
    Caballero, L.
    Climent, V.
    Marin, F.
    Garcia Honrubia, A.
    Heras, S.
    Perez Berbel, P.
    Sanchez, J.
    Moreno, M.
    Quintanilla, M. A.
    Sogorb, F.
    EUROPEAN HEART JOURNAL, 2010, 31 : 38 - 39